Literature DB >> 7640158

A retrospective analysis of the prevalence of HIV seropositivity and its demographics in the normal healthy volunteer population of a phase-I clinical drug study unit.

R Jagathesan, L D Lewis, T G Mant.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7640158      PMCID: PMC1365139          DOI: 10.1111/j.1365-2125.1995.tb04480.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  HIV transmission, travel, and Thailand.

Authors:  A Noone; N Macdonald; B Evans; J Heptonstall
Journal:  BMJ       Date:  1992-12-05

2.  Efficient production of antigenic mosaic reassortants of rotavirus with the aid of anti-VP4 and anti-VP7 neutralizing monoclonal antibodies.

Authors:  N Kobayashi; K Taniguchi; T Urasawa; S Urasawa
Journal:  J Virol Methods       Date:  1993-09       Impact factor: 2.014

3.  [The rectus femoris muscle--the beginning tendon, its functional significance].

Authors:  M Doskocil; M Med; T Vimmer
Journal:  Acta Chir Orthop Traumatol Cech       Date:  1987-04       Impact factor: 0.531

4.  HIV screening in 'healthy' volunteers and Ethics Committees.

Authors:  J Sánchez; A Costa; A Fresquet; M Abadías; A Bartlett
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

5.  Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging.

Authors:  I Grant; J H Atkinson; J R Hesselink; C J Kennedy; D D Richman; S A Spector; J A McCutchan
Journal:  Ann Intern Med       Date:  1987-12       Impact factor: 25.391

Review 6.  Drug hypersensitivity reactions and human immunodeficiency virus disease.

Authors:  P J Bayard; T G Berger; M A Jacobson
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992-12

Review 7.  Voluntary screening for human immunodeficiency virus (HIV) infection. Weighing the benefits and harms.

Authors:  B Lo; R L Steinbrook; M Cooke; T J Coates; E J Walters; S B Hulley
Journal:  Ann Intern Med       Date:  1989-05-01       Impact factor: 25.391

8.  Screening for human immunodeficiency virus: a survey of British clinical pharmacology units.

Authors:  M Thomson; W G Haynes; D J Webb
Journal:  Br J Clin Pharmacol       Date:  1993-10       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.